BioMarin Pharmaceutical Statistics
NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
60.41-1.01 (-1.64%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioMarin Pharmaceutical by the numbers
BioMarin Pharmaceutical has a market capitalization of $11.70 billion based on 193.69M shares outstanding. With trailing EPS of $-0.10, BioMarin Pharmaceutical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.6% above its 50-day average and 3.2% above its 200-day average.
Average daily trading volume is 2.35M shares, or about $141.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BMRN valuation vs. peer median
| Metric | BMRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.70B | $10.99B | +6% |
| Forward P/E | 9.6 | 22.5 | -57% |
| Avg. volume | 2.35M | 1.56M | +50% |
Peer median across 8 companies: RDY, ELAN, TGTX, JAZZ, BBIO, SYRE, MDGL, PRAX.
Valuation
- Market cap
- $11.70B
- Forward P/E
- 9.60
- Price / sales (latest FY)
- 3.63
- EPS (TTM)
- $-0.10
- Shares outstanding
- 193.69M
Price and trading
- Previous close
- 61.42
- Open
- 61.98
- Day range
- 59.84 – 62.00
- 52-week range
- 49.26 – 70.98
- 52-week change
- +10.46%
- Beta
- —
- Volume
- 6.06M
- Average volume
- 2.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 11.70B
- Forward Pe
- 9.60
- Eps
- -0.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 70.98
- Week52 Low
- 49.26
- Avg Volume
- 2.35M
- Shares Outstanding
- 193.69M
- Ma50
- 58.32
- Ma200
- 58.53
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -14.89%
- Pct From52w Low
- 22.63%